Pertussis control: time for something new?

Centers for Disease Control and Prevention, Division of Bacterial Diseases, 1600 Clifton Road, Mailstop C-25, Atlanta, GA 30333, USA.
Trends in Microbiology (Impact Factor: 9.81). 04/2012; 20(5):211-3. DOI: 10.1016/j.tim.2012.03.003
Source: PubMed

ABSTRACT Childhood acellular pertussis vaccines were licensed and implemented in the US in the 1990s following an effort to improve on the safety profile of whole-cell vaccines. However, waning of immunity from acellular vaccines may be driving the recent resurgence of pertussis, raising the need to consider new prevention strategies.

  • Archivos argentinos de pediatrĂ­a 08/2013; 111(4):295-302. DOI:10.5546/aap.2013.295 · 0.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pertussis, or whooping cough, has had a dramatic resurgence in the past several years and is the most common vaccine-preventable disease in the world. The year 2012 marked the most cases in the United States in > 50 years. Large outbreaks have occurred in multiple states, and infant deaths have drawn the attention of not only health-care providers but also the media. Although the disease is theoretically preventable by vaccination, it remains a challenge to control. New vaccination strategies have been implemented across different age groups and populations of patients, but vaccine coverage remains dismally low. Acellular vaccines, although safe, do not afford the same long-lasting immunity as the previously used whole-cell vaccine. Ultimately, improvements in the development of vaccines and in vaccination coverage will be essential to decrease the burden of pertussis on society. This article provides a review of pertussis infection and discusses advances related to the epidemiology, diagnosis, treatment, and prevention of infection, as well as continued areas of uncertainty.
    Chest 07/2014; 146(1):205-214. DOI:10.1378/chest.13-2942 · 7.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pertussis is resurgent in many countries, perhaps owing in part to waning immunity after acellular pertussis vaccination. We consider the options for improving current vaccines as well as other strategies to control pertussis.
    Expert Review of Vaccines 08/2014; DOI:10.1586/14760584.2014.944166 · 4.22 Impact Factor